GSI Creos Corporation
GSI Creos Corporation (8101.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for GSI Creos Corporation (8101.T), covering cash flow, earnings, and balance sheets.
GSI Creos Corporation (8101.T) Income Statement & Financial Overview
Explore comprehensive income reports for GSI Creos Corporation 8101.T, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $46.24B | $39.65B | $47.12B | $32.53B |
| Cost of Revenue | $41.97B | $35.63B | $42.71B | $28.38B |
| Gross Profit | $4.27B | $4.02B | $4.41B | $4.16B |
| Gross Profit Ratio | $0.09 | $0.10 | $0.09 | $0.13 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.94B | $3.21B | $3.49B | $3.27B |
| Operating Expenses | $3.94B | $3.21B | $3.49B | $3.27B |
| Total Costs & Expenses | $45.91B | $38.84B | $46.20B | $31.65B |
| Interest Income | $38.00M | $20.00M | $31.00M | $20.00M |
| Interest Expense | $86.00M | $40.00M | $78.00M | $75.00M |
| Depreciation & Amortization | $121.00M | $89.00M | $106.50M | $103.00M |
| EBITDA | $610.00M | $897.00M | $1.03B | $1.13B |
| EBITDA Ratio | $0.01 | $0.02 | $0.02 | $0.03 |
| Operating Income | $336.00M | $808.00M | $919.00M | $886.00M |
| Operating Income Ratio | $0.007 | $0.02 | $0.02 | $0.03 |
| Other Income/Expenses (Net) | $32.00M | -$36.00M | -$84.00M | $70.00M |
| Income Before Tax | $368.00M | $772.00M | $835.00M | $956.00M |
| Income Before Tax Ratio | $0.008 | $0.02 | $0.02 | $0.03 |
| Income Tax Expense | -$219.00M | $238.00M | $246.00M | $307.00M |
| Net Income | $586.00M | $535.00M | $589.00M | $648.00M |
| Net Income Ratio | $0.01 | $0.01 | $0.01 | $0.02 |
| EPS | $47.75 | $43.59 | $48.00 | $52.82 |
| Diluted EPS | $47.75 | $43.59 | $48.00 | $52.82 |
| Weighted Avg Shares Outstanding | $12.27M | $12.27M | $12.27M | $12.27M |
| Weighted Avg Shares Outstanding (Diluted) | $12.27M | $12.27M | $12.27M | $12.27M |
The company's financials show resilient growth, with revenue advancing from $32.53B in Q1 2024 to $46.24B in Q4 2024. Gross profit remained healthy with margins at 9% in Q4 2024 compared to 13% in Q1 2024. Operating income hit $336.00M last quarter, sustaining a consistent 1% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $610.00M. Net income rose to $586.00M, while earnings per share reached $47.75. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan